SCHEMBL4875367

SCHEMBL4875367

FC(F)(F)c1ccnn1-c1cccc(Cl)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 3/20 0.38
HTR3B O95264 3/20 0.38
HTR3A P46098 3/20 0.38
HTR3D Q70Z44 3/20 0.38
HTR3C Q8WXA8 3/20 0.38
ALDH1A1 P00352 2/20 0.38
TSHR P16473 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP1A2 P05177 2/20 0.36
MEN1 O00255 1/20 0.36
CYP2D6 P10635 1/20 0.36
ALOX15 P16050 1/20 0.36
NFKB1 P19838 1/20 0.36
KMT2A Q03164 1/20 0.36
ALOX5 P09917 2/20 0.36
KDM4E B2RXH2 1/20 0.35
MAPT P10636 2/20 0.33
POLB P06746 1/20 0.33
CYP2C9 P11712 1/20 0.33
KCNN3 Q9UGI6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4882320 0.75 OXTR (0.49) KDM4EPOLBOXTRAVPR1A
SCHEMBL15015880 0.72 HTR3E (0.36) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL4883251 0.71 HPGD (0.44) MEN1KMT2AKDM4EMAPTNTRK1
SCHEMBL27955916 0.71 P2RX7 (0.42) KDM4E
SCHEMBL4854437 0.69 KDM4E (0.47) ALDH1A1TSHRCYP3A4CYP1A2MEN1
SCHEMBL4886359 0.68 KDM4E (0.40) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL4988967 0.68 KDM4E (0.56) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL31118756 0.68 EPHX2 (0.40) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL30987262 0.68 KDM4E (0.41) ALDH1A1CYP1A2MEN1KMT2AKDM4E
SCHEMBL16321386 0.68 KDM4E (0.41) ALDH1A1CYP1A2MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080064690-A1 PYRAZOLE-AMIDES AND -SULFONAMIDES ICAGEN, INC. (US) 2008-03-13 US disclosed
US-7223782-B2 Pyrazole-amides and -sulfonamides ICAGEN, INC. (US) 2007-05-29 US disclosed
US-20050049237-A1 Pyrazole-amides and -sulfonamides ICAGEN, INC. (US) 2005-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064690-A1 PYRAZOLE-AMIDES AND -SULFONAMIDES SCN3A, TRPV3, HCN3 HTR3E 968/4885HTR3B 714/4885HTR3A 431/4885
US-20050049237-A1 Pyrazole-amides and -sulfonamides SCN3A, TRPV3, HCN3 HTR3E 968/4885HTR3B 714/4885HTR3A 431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.